What are the latest advances in HBOT research?
In recent years it has been discovered that HBOT may be beneficial to patients with AIDS, Alzheimers, multiple sclerosis, bone disorders, spinal chord injuries, circulatory problems and radiation treatment complications. With the inclusion of negative ions with Hyperbaric therapy, if approved to do so, HyperStealth may conduct research into these areas to see if the addition of the ions improves these conditions. HyperStealth intends to have our chambers 510K approved with the FDA (Food and Drug administration in the U.S). Past 510K approvals of other Hyperbaric chambers allow for treatment of approved uses as set out by the UMHS (Undersea and Hyperbaric Medical Society) Approved Indications: The following indications are approved uses of hyperbaric oxygen therapy as defined by the Hyperbaric Oxygen Therapy Committee. 1 Air or Gas Embolism 2 Carbon Monoxide Poisoning Carbon Monoxide Poisoning Complicated by Cyanide Poisoning 3 Clostridal Myositis and Myonecrosis (Gas Gangrene) 4 Crush
